ZegeneX Therapeutics: Executive Overview & Clinical Vision
Overview & Scientific Context
A comprehensive overview of ZegeneX Therapeutics' revolutionary small-molecule regenerative wound healing platform, its translational origins at the University of Pittsburgh, and upcoming IND-enabling clinical trajectory for diabetic foot ulcers.
Recorded at the University of Pittsburgh and ZegeneX laboratories, documenting the development of first-in-class small-molecule therapeutics engineered to accelerate cellular re-epithelialization in chronic wounds.
Related Video Presentations
Complete 5-Phase Wound Healing Mechanism of Action
Comprehensive scientific animation detailing the 5 biological phases of wound repair—from initial platelet plug formation and immune debridement to cellular proliferation, myofibroblast contraction, and epidermal remodeling.
Translational Laboratory Footage: Zebrafish Screening & Kinase Assay
Exclusive footage inside the University of Pittsburgh developmental biology laboratories showcasing high-throughput transgenic zebrafish genetic assays, fluorescent biosensors, cellular re-epithelialization imaging, and translational tissue regeneration research.
Zegen-X5 Product Application & Shelf-Stable Delivery Demo
Detailed demonstration of the ambient-stable topical application mechanism for Zegen-X5, demonstrating simple point-of-care application for chronic wound beds without requiring cold-chain refrigeration or complicated reconstitution.